Therapeutic targets of rosuvastatin on heart failure and associated biological mechanisms: A study of network pharmacology and experimental validation-Reference-Cited by-同舟云学术

Therapeutic targets of rosuvastatin on heart failure and associated biological mechanisms: A study of network pharmacology and experimental validation

Published:2021-03 Issue: Volume:895 Page:173888
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Lian Zheng,Song Jun-Xian,Yu Shi-Ran,Su Li-Na,Cui Yu-Xia,Li Su-Fang,Lee Chong-Yoo,Liang Hui-Zhu,Chen Hong

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference24 articles.

1. Rosuvastatin inhibits inflammatory response and resists fibrosis after myocardial infarction;Bao;Eur. Rev. Med. Pharmacol. Sci.,2018

2. 2016 ESC/EAS guidelines for the management of dyslipidaemias;Catapano;Eur. Heart J.,2016

3. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme;Dinarello;Ann. N. Y. Acad. Sci.,1998

4. Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease;DiNicolantonio;Postgrad. Med.,2013

5. Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction;Dourado;Braz. J. Med. Biol. Res.,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the Macrophage-Associated Inflammasome Exacerbates Myocardial Fibrosis Through the 15-HETE-Mediated Pathway in Acute Myocardial Infarction;Engineering;2024-06

2. Identification and analysis of the molecular targets of statins in colorectal cancer;Pathology - Research and Practice;2024-04